Return to News

COSMIC News

Celebrating 30 years of opportunity, evolution and groundbreaking science with COSMIC’s Karen McLaren

19 Dec 2024

As we near the end of 2024, there’s more than just the holidays being celebrated at COSMIC, Karen McLaren (Head of Product and Delivery), has recently marked an incredible milestone: her 30th anniversary working at the Wellcome Sanger Institute. Karen currently leads the evolution of COSMIC’s product management strategy and oversees critical change delivery initiatives, combining her extensive experience in project and product management with a deep background in genomics. Throughout her rich and varied career, Karen has embraced many roles, growing and adapting her skill set to meet the ever-changing landscape of genomic science.

We sat down with Karen to reflect on her time at the Sanger Institute, and how it led to her a successful career in project management within the genomics industry.

A photo of Karen McLaren

What first drew you to The Sanger Institute?

What first drew me to the Sanger Institute was a case of opportunity meeting interest. During my degree, I compared Sanger sequencing with Maxam-Gilbert and concluded that Sanger to be the superior option, though at the time it was limited by cost. It was just two months after this study, a friend happened to spot an advertisement for a Technical Assistant position in the newspaper, clipped it out, and posted it through my door. The science was incredibly new and exciting, and while I was applying for multiple scientific roles, I felt incredibly fortunate to live so close to the exact kind of groundbreaking work I wanted to be part of.

I’ve always believed that you have to take the opportunities afforded to you and make something of them, and that mindset has allowed me to evolve personally and professionally.

From the moment I started, I knew Sanger was special, there was nothing like it anywhere else. In my early days I worked for John Sulston on his C. elegans nematode project, which was an extraordinary experience. You could feel that we were breaking new ground, yet we were being led by an incredibly humble man, which made it all the more inspiring.

What have been your most memorable moments as part of the institute?

There are two moments in particular that stand out from my time at the Institute. First was being in London alongside John Sulston and team when the paper Genome sequence of the nematode C. elegans: a platform for investigating biology was published. A stand out memory from this celebration was a particular quote from Sulston’s speech: This is not the end, just the beginning. The feeling that the entire room truly believed in this potential and the anticipation of what was to come was palpable, it was an incredibly proud moment.

Genome sequence of the nematode C. elegans: a platform for investigating biology

I can’t reflect on my time at the Sanger Institute without highlighting the completion of the first human genome through the Human Genome Project. Nobody had ever done anything like it before, it was a groundbreaking achievement that trailblazed international collaboration. The team at The Sanger Institute in particular played a pivotal role, undertaking and completing 33.3% of the genome, making us the largest contributing lab to the project.

Beyond the scientific accomplishment, the Human Genome Project became a dynamic resource for scientists worldwide, not a stagnant entity. For many, this transition to an open-access model was daunting, but as John Sulston had said during his own work, this was only the beginning. The goalposts were constantly moving, which was both challenging and exciting, and it was this ever-evolving environment that ultimately steered me toward project management.

Genome sequence of the nematode C. elegans: a platform for investigating biology

Can you tell me a little about how your role has changed over the years?

Over the years, my role has evolved significantly as the priorities of the Institute have shifted, and I’ve thrived in this environment while equally enjoying the opportunity to help others adapt to change. As I have mentioned, I started my career as a Technical Assistant working on C. elegans with Sulston, before progressing to Senior Technical Assistant and eventually leading a Human Genome Project team. As my career developed, I led a wet lab team while collaborating with bioinformaticians analysing the data (at the time, this was a relatively new role!).

I’ve always approached challenges with a logical mindset, believing that mistakes are often rooted in processes rather than people, and I thoroughly enjoy working with teams to understand workflows and drive efficiencies. Through this, I’ve found that being data-driven and considering the human element aren’t mutually exclusive; in fact, they complement each other. My career has also seen me take on diverse projects, including managing lab reconfigurations and relocations, overseeing large-scale office restructuring for 150 people, implementing bespoke software and SaaS systems, and leading workforce planning and transformation initiatives, to name just a few.

What are the most significant changes you have noticed over the course of your time here?

Over the course of my time here, I’ve noticed significant changes that reflect both the evolution of science and the workplace. Beyond the cultural shifts that have brought day-to-day operations into the modern world, such as flexible working and a stronger emphasis on work-life balance, the role of sequencing has transformed dramatically. When I started, sequencing was the science, but over time, it became the foundation supporting the analysis, which has now taken center stage. I’ve also witnessed how the landscape of an entire industry can be affected by work happening on just one campus.

What has remained consistent throughout, however, is our commitment to staying modern and ahead of the curve; whether it’s through pioneering science, forward-thinking approaches to people, or continually pushing boundaries in the field.

About

COSMIC, the Catalogue Of Somatic Mutations In Cancer, is the most comprehensive resource for exploring the impact of somatic mutations in human cancer. Here on our news page we aim to give you an insight into what we are doing and why. We will keep you updated with new developments and release information as well as any events we are hosting.

Tags

release

workshop

website

curation

COSMIC-3D

vacancies

downloads

user experience

data submission

website update

Cancer Gene Census

mutation ID

Hallmarks of Cancer

GRCh37

drug resistance

GRCh38

video

tutorial

birthday

International Women's Day

literature

mutational signatures

Mesothelioma

conference

AACR

gene

Bile duct cancer

cholangiocarcinoma

Europe PMC

Service announcement

blog

survey

updates

v90

search

cosv

updated

CDS

Fasta

cDNA

disease focus

world cancer day

new product

cmc

DIAS

Actionability

COSMIC

webinar

introduction to cosmic

mutations

celebrating success

Oncology

oncology trials

precision medicine

clinical trials

precision oncology

cancer

genomics

immuno oncology

breast cancer

cosmic v95

bioinformatics

cancermutationcensus

COSMICv95

Lung Cancer

Glioblastoma

testicular cancer

cancer prevention

biomarkers

Cancer Research

tumour microenvironment

copy number variants

ageing

genes

genome

clones

smoking

Clonal haematopoesis

tumour

inherited

disease

individuals

risk

variants

leukaemia

Myelodysplastic syndrome

lymphoma

haematological cancers

Myeoloproliferative neoplasms

myeloma

haematological

somatic mutations

blood cancers

blood cancer

NRAS

acral lentiginous melanoma

BRAF

melanoma

driver gene

skin cancer

uv light

Mexico

chromosome

acral melanoma

breed predisposition

genetics

PIK3CA

driver genes

canine cancer

data ecosystem

database

canine

tumour board

barrett's oesophagus

oesophageal cancer

upper gi

gene panel

cell lines project

Wellcome Sanger Institute

sanger

uv radiation

uv nail lamp

SBS18

reactive oxygen species

DNA damage

uv damage

sebaceous gland carcinoma

Kaposi cell carcinoma

Lynch syndorme

carcinoma

cancerresearch

Merkel cell carcinoma

Muir-torres syndrome

MLH1

sanger institute

Mike Stratton

cancer genome project

BRCA2

mutographs

resistance mutations

IWD24

Women in STEM

IT

computational biology

STEM career

computer science

v100

cancer mutation census

genetic oncology

#genomics

#high medical need

#genetics

#cancer mutation census

#cancer gene census

#whole genome sequencing

#oncology

#whole exome sequencing

#cosmic

#somatic mutation

#thyroid cancer

NGS panel

product management

wellcome genome campus

human genome project

c elegans

project management